Related Experiment Videos
Congenital adrenal hypoplasia and DAX-1 gene mutations
1Département d'Endocrinologie et Maladies Métaboliques. CHU de Bordeaux, Hôpital du Haut Lévêque, 33604 Pessac, France.
Abstract:
DAX-1 is a member of the orphan nuclear hormone receptor family. Its mutations cause X-linked adrenal hypoplasia congenita, a disease characterized by adrenal insufficiency due to impaired organogenesis of the adrenal cortex and hypogonadotrophic hypogonadism. We review herein the pathologic and clinical features of the disease and describe some recent advances in the clinical expression of X-linked adrenal hypoplasia congenita.
Insights
Mutations in DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome gene 1) cause a rare genetic disorder. This review covers the pathology, clinical features, and recent advances in X-linked adrenal hypoplasia congenita.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- DAX-1 is an orphan nuclear hormone receptor.
- Mutations in DAX-1 lead to X-linked adrenal hypoplasia congenita (AHC).
- X-linked AHC presents with adrenal insufficiency and hypogonadotropic hypogonadism.
Purpose of the Study:
- To review the pathology and clinical features of X-linked AHC.
- To highlight recent advances in understanding the clinical expression of X-linked AHC.
Main Methods:
- Literature review of pathological and clinical findings.
- Analysis of recent clinical case studies and research.
Main Results:
- DAX-1 mutations impair adrenal cortex organogenesis, causing adrenal insufficiency.
- The condition also results in hypogonadotropic hypogonadism.
- Recent studies show evolving clinical manifestations and diagnostic approaches.
Conclusions:
- X-linked AHC is a complex endocrine disorder caused by DAX-1 dysfunction.
- Understanding its pathology and clinical spectrum is crucial for patient management.
- Ongoing research continues to refine our knowledge of X-linked AHC.